Transluminal angioplasty of venous stenoses in polytetrafluoroethylene vascular access grafts  by Schwab, Steve J. et al.
Kidney International, Vol. 32 (/987), pp. 395—398
Transluminal angioplasty of venous stenoses in
polytetrafluoroethylene vascular access grafts
STEVE J. SCHWAB, M0HsIN SAEED, STEVEN K. SUSSMAN, RICHARD L. MCCANN,
and DELFORD L. STICKEL
Departments of Medicine, Radiology, and Surgery, Duke University Medical Center, Durham, North Carolina, USA
Transluminal angioplasty of venous stenoses in polytetrafluoroethylene
vascular access grafts. Since 1984, percutaneous transluminal angio-
plasty (PTA) utilizing high pressure balloon catheters has been used as
an initial approach to restore patency of PTFE (polytetrafluoroeth-
ylene, GORE-TEX) hemodialysis vascular access grafts. Seventeen
stenotic lesions detected by fistulogram underwent elective PTA.
Twelve of these lesions were detected after thrombectomy and five
were detected because of increased venous pressures during dialysis.
Fourteen attempts at PTA were completely successful in restoring
functional patency to the vascular graft. Three attempts were unsuc-
cessful; two of these three grafts were subsequently repaired surgically.
Venous stenoses that extended for greater than 6 cm were not consid-
ered for PTA. We conclude that PTA is a technique of promise in the
non-surgical salvage of failing PTFE grafts. PTA can prolong the useful
life of PTFE vascular access grafts and can be performed on an
outpatient basis, eliminating the hospitalization that is usually required
for surgical revision.
Long—term vascular access for hemodialysis is provided by
the use of endogenous (native) or synthetic arteriovenous
fistulae. The introduction of synthetic vascular prostheses for
formation of these AV fistulae has allowed an expansion in the
number, type, and age of patients who can be maintained on
hemodialysis [1—4]. At Duke University Medical Center, over
three—fourths of our current vascular accesses are composed of
synthetic PTFE. A major technical problem currently confront-
ing nephrologists and vascular angioaccess surgeons is main-
taining patency in hemodialysis access grafts, especially in an
aging hemodialysis population with limited vascular access sites
[1, 2]. The most common anatomic cause of thrombosis in
PTFE vascular access grafts is venous stasis [1]. Among other
causes, this venous stasis may be mediated by high—grade
stenotic lesions at the vein—graft anastomosis site, or anywhere
more proximal in the venous circulation (Fig. 1). These venous
stenoses have characteristically been treated by surgical revi-
sion of the vascular access graft [1-4].
This report summarizes our experience over the past two
years at Duke University Medical Center with the use of
thrombectomy, surgical revision, and percutaneous translumi-
nal angioplasty (PTA) using high—pressure balloon catheters in
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the treatment of venous stenotic lesions in PTFE vascular
access grafts.
Methods
Patients
From September 1984 through October 1986, 17 percutane-
ous transluminal angioplasty—procedures were performed on
stenotic venous lesions in PTFE vascular access grafts (Table
I). The 13 patients presented in this report include nine males
and four females with an age range between 25 and 70 years,
and a mean age of 47 years. The cause of renal failure was
hypertension in eight patients, glomerulonephritis in two pa-
tients, diabetes in two patients, and polycystic kidney disease in
one patient. Six of these patients had a total of seven, upper arm
PTFE loop—grafts while four had forearm loop grafts. Two
patients had straight PTFE grafts in the forearm, and one
patient had an axillary—to—axillary transthoracic straight PTFE
graft. Ten lesions occurred at the vein—graft anastomosis, with
seven lesions occurring more proximally in the venous circula-
tion (Fig. 1). Figure 2 outlines the patient selection process for
PTA. All PTA procedures were performed in the Vascular
Radiology Suite at Duke University Medical Center or the
Durham Veteran's Administration Medical Center by one of
four interventional radiologists. Fistulograms were performed
to evaluate vascular access grafts following successful
thrombectomy (12 instances), or to evaluate limb swelling and
increased mean venous pressure during dialysis (5 instances).
Contrast injections were made by cannulation of the arterial
limb, the graft itself, or the venous limb of the fistula. With
venous or graft injections a pressure cuff was applied to the
upper arm to allow retrograde filling of the artery. Cuff inflation
was limited to approximately 30 seconds to avoid thrombosis.
In some cases, visualization of the veins as far proximal as the
subclavian vein was necessary to document clinically suspected
lesions. The approach chosen for angioplasty varied; however,
venous lesions were, in general, approached through the distal
aspect of the vein if it could be identified on the fistulogram, or
through the PTFE graft itself (Fig. I). If the lesion was very
proximal, a femoral vein approach was occasionally used.
Intravenous heparin, 3000 to 5000 units, was given, and after
successful crossing of the stenosis dilatation attempts were
begun with an oversized high pressure angioplasty balloon
catheter (6 to 15 mm balloon diameter, 7 French catheter, burst
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Fig. 1. Anatomic description of PTFE vascular access graft in the
forearm position.
pressure 17 atmospheres, Medi-Tech, Inc., Watertown, Massa-
chusetts, USA). The balloon was inflated for one to two
minutes each time up to a maximum of five inflations. Anasto-
motic venous stenotic lesions did not always expand completely
and in some cases of tight residual lesions, teflon dilators were
employed to dilate up to a 12 French size. Contrast studies were
obtained post-PTA to document flow across the stenotic lesion
post-dilatation. Hemostasis was obtained at the end of the
procedure by 15 to 20 minutes of manual compression. Figure 3
provides a representative example of the radiographic findings
pre- and post-PTA. Vascular surgeons were kept on standby in
all instances and two patients (Table 1, #7 & #8) were taken for
immediate surgical revision after technical failure of the PTA
procedure. There were no bleeding or other technical compli-
cations resulting in loss of the vascular access graft. There were
no infections or other complications.
Results
During this study 17 venous stenoses in PTFE hemodialysis
vascular access grafts were detected by fistulogram in thirteen
patients (Table 1). The method by which these patients were
selected for PTA is outlined in Figure 2.
During this period, 62 new PTFE hemodialysis vascular
access grafts were placed and 131 thrombectomies of PTFE
grafts were performed (Fig. 2). Eighteen thrombectomies (14%)
were unsuccessful necessitating placement of a new PTFE
graft. Ten PTFE grafts (8%) were surgically revised at throm-
bectomy because the graft outflow tract was sized as less than
4 mm or the inflow tract was sized as less than 3 mm by the use
of coronary dilators. Of 103 successful thrombectomies, 70
underwent fistulogram within seven days of thrombectomy. In
33 instances, fistulograms were not obtained. Of 70 fistulo-
grams, 54(77%) did not show an anatomic lesion. Sixteen (23%)
showed a significant anatomic lesion. Three stenotic venous
lesions (4%) were greater than 6 cm in length and were referred
directly for surgical revision. One arterial stenosis was noted
and underwent PTA. Twelve venous stenoses (17%) were noted
and underwent PTA (Fig. 2).
Eight patients were studied by fistulogram because of ele-
vated venous pressures during dialysis (Fig. 2). Three (38%) of
these patients did not have a significant stenotic lesion. Five
(62%) were noted to have a venous stenosis and underwent
elective P1'A. Elevated venous pressure resolved after PTA in
all instances. Successful percutaneous transluminal repair was
accomplished in 14 instances (82%). Successful PTA was de-
fined as graft patency sufficient for routine hemodialysis for a
duration of greater than six months following the procedure, or
functional patency at death of the patient or at the time of this
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Fig. 2. Patient selection process for PTA. Each number represents one
event. Multiple thrombectomies may occur in an individual patient.
review. Seven of the lesions occurred proximal to the site of the
vein—graft anastomosis (Fig. 1), and seven (100%) were repaired
by PTA (Table 1). Ten lesions occurred at the vein—graft
anastomosis (Fig. 1), and seven (70%) were repaired success-
fully (Table 1). One lesion occurred at the artery graft anasto-
mosis and it was successfully repaired. Two patients each
underwent three angioplasties. In two of these instances (#1C
and #2B, Table 1), a lesion underwent successful PTA for
re-stenosis following a prior angioplasty. Among 14 successful
dilatations in 10 separate grafts, follow—up of six months or
longer to date is available in 11 cases. The mean patency
currently being 14 months. Among the ten grafts dilated, five
are still patent and when completely followed may significantly
lengthen the mean patency time.
PTA was unsuccessful in three attempts. In two instances,
technical failure of the PTA procedure required immediate
surgical revision of the fistula (#7 & #8, Table 1). The third
unsuccessful attempt occurred in an unused graft that had never
matured adequately. Recurrent thrombosis due to poor venous
runoff had necessitated multiple prior thrombectomies in the
fistula (#5, Table 1). All three unsuccessful repairs occurred
when the stenotic lesion was at the vein—graft anastomosis.
DiscussIon
Providing satisfactory angioaccess for hemodialysis remains
one of the most difficult and complicated problems currently
confronting nephrologists in the management of hemodialysis
patients. Palder et al and Munda et al have recently reported
their experience with angioaccess surgery [1, 2]. Endogenous
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Fig. 3. A. Diagnostic fistulogram shows a stenosis at the Gore-Tex graft—vein anastomosis (straight white arrow). The proximal vein is occluded
by a pressure cuff (arrow head). Black arrow shows distal vein. The arterial limb is not shown. B. Fistulogram after PTA shows adequate dilatation
of the stenosis (arrow), with good proximal venous runoff.
Table 1. PTA results in PTFE grafts
Graft type Artery—vein Lesion Follow—up, months
1) A. Loop Brachial—cephalic Proximal vein (cephalic) 10
B. Loop Brachial—cephalic Proximal vein (subclavian) 10
C. Loop Brachial—brachial Proximal vein (subclavian) 6
2) A. Straight Axillary—axillary Anastomotic (axillary) 12
B. Straight Axillary—axillary Anastomotic (axillary) 6
C. Straight
3) Straight
Axillary—axillary
Radial—brachial
Proximal vein (subclavian)
Anastomotic (brachial)
6
5i
4) Straight Radial—brachial Anastomotic (brachial) 14
5) Straight Radial—brachial Anastomotic (brachial) 0.5 Inadequate outflow vein'
6) Loop Brachial—axillary Anastomotic (axillary)
7) Loop Brachial—brachial Anastomotic (brachial) Balloon rupture surgical revision
8)
9)
Loop
Loop
Radial—brachial
Brachial—brachial
Anastomotic (brachial)
Proximal vein (subclavian)
Spasm-thrombosis surgical revision
6b
10) Loop Radial—basilic Proximal vein (subclavian) I 1d
II) Loop Radial—basilic Proximal vein (subclavian) 7
12) Loop Radial-basilic Anastomotic (basilic) 13"
13) Loop Radial—basilic Anastomotic (basilic) 2L'
a Unrelated death, graft patentb To date
Graft never functional
d Graft infection
AV fistulas remain an excellent long—term vascular access. to poor vein quality is not uncommon [11, An increasing number
However, as older and more debilitated patients enter hemodi- of patients currently maintained on hemodialysis have their
alysis, it is becoming progressively more difficult to find satis- initial vascular accesses formed with grafts of PTFE synthetic
factory veins to form an endogenous fistula. A 24 to 35% failure tubing anastomosed to native arteries and veins. Patency at one
rate for new endogenous AV fistulas within the first month due year has varied from 55 to 70% with two—year graft survival of
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approximately 50% [1—4]. Stenotic lesions in the venous limb
are the most common anatomic cause of thrombosis of PTFE
hemodialysis grafts [1]. These lesions can occur at the
vein—graft anastomosis associated with venous intimal hyper-
plasia and fibrosis or can occur more proximally in the venous
circuit (Fig. 1). Arterial stenoses are much less common [1].
Various techniques have been advocated to restore patency
in these synthetic vascular grafts. Surgical thrombectomy fol-
lowed by surgical revision remains the most commonly prac-
ticed method of restoring patency [1—4]. This technique al-
though successful, requires hospitalization and a recovery
period prior to use of the vascular access. It also has the
disadvantage of progressive loss of future venous access sites
as bypass grafts extend more proximally up the arm. Several
investigators have evaluated streptokinase lysis of thrombosed
vascular access grafts followed by PTA [5—7]. Success rates
varying from 30 to 50% with this technique have been reported
[5—7]. The extended time period sometimes required for clot
lysis, mediocre success and bleeding complications have pre-
vented wide spread acceptance of this technique. PTA in the
treatment of venous high—grade lesions has been reported as
being reasonably successful [8, 9] and completely unsuccessful
[10]. Our high (82%) success rate in restoring patency in PTFE
grafts is based upon early fistulogram evaluation of persistent
high—venous pressures and the aggressive combination of sur-
gical thrombectomy with PTA. Most patients who require
thrombectomy can now have this performed on an outpatient
basis with elective fistulogram performed prior to the next
dialysis. High—grade stenotic lesions can be referred rapidly for
PTA with surgical standby. We believe it is this combination of
early surgical thrombectomy followed by fistulogram and PTA
that has led to our high patency rate. It is possible to perform all
three procedures on an outpatient basis. Based on previous
observations, stenoses that extend for long segments (>6 cm)
should not be considered for angioplasty but should probably be
surgically revised [11] as is the practice described in this study.
In our practice tight vein—graft stenoses (<4 mm) detected at
thrombectomy are surgically revised at thrombectomy (Fig. 2).
Our success rate with PTA has been 100% with proximal
venous lesions. As previously reported, stenoses at the
vein—graft anastomosis are most often secondary to intimal
hyperplasia and fibrosis, and are frequently more difficult to
resolve with PTA [9]. The use of high pressure balloons and
longer inflation times has proved helpful; however, even with
this method the anastomotic lesion may only partially resolve.
Nevertheless, even incomplete resolution of these stenoses
often restores satisfactory function. Recurrent lesions can be
treated again with PTA, thus maximizing graft longevity. Two
of ten (20%) vein—graft anastomosis stenoses failed to be
successfully dilated (Table 1). One failure resulted from rupture
of the PTA balloon during attempted dilatation. Persistant
venous spasm and thrombosis caused the second failure. De-
spite these failures, the vascular grafts were surgically salvaged
in both instances. The only other unsuccessful PTA occurred
secondary to inadequate caliber of venous runoff in a graft
which had failed to mature (Table 1, #5).
Venous outflow occlusions are the most common anatomic
cause of loss of patency in PTFE hemodialysis, vascular access
grafts [1]. In thrombosed grafts, the combination of thrombec-
tomy followed by fistulogram and PTA is a promising combi-
nation to preserve graft patency. When PTA is not successful,
surgical revision remains possible.
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